Actualisation de la conduite à tenir en cas de lésions à papillomavirus humains (HPV)

Adam, 1998, Is human papillomavirus testing an effective triage mathod for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?, Am. J. Obstet. Gynecol., 178, 1235, 10.1016/S0002-9378(98)70328-X Bosch, 1995, Prevalence of Human Papillomavirus in Cervical Cancer: a worldwide perspective, J. Natl. Cancer Inst., 87, 796, 10.1093/jnci/87.11.796 Bosch, 2001, Papillomavirus research update: highlights of the Barcelona HPV 2000 International Papillomavirus Conference, 54, 163 Clavel, 1998, Comparative analysis of the human papillomavirus detection by Hybrid Capture® assay and routine cytology screening to detect high grade cervical lesions, Int. J. Cancer, 75, 525, 10.1002/(SICI)1097-0215(19980209)75:4<525::AID-IJC6>3.0.CO;2-V Clavel, 1998, Hybrid Capture II®, a new sensitive test for human papillomavirus detection, J. Clin. Pathol., 51, 737, 10.1136/jcp.51.10.737 Clavel, 1999, Hybrid Capture II®-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1 518 women, Br. J. Cancer, 80, 1306, 10.1038/sj.bjc.6690523 Clavel, 2001, Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7 932 women, Br. J. Cancer, 89, 1616, 10.1054/bjoc.2001.1845 Conaglen, 2001, A prospective study of the psychological impact on patients of first diagnosis of human papillomavirus, Int. J. STD & AIDS, 12, 651, 10.1258/0956462011923877 Cox, 1995, Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance, Am. J. Obstet. Gynecol., 172, 946, 10.1016/0002-9378(95)90026-8 Cuzick, 1999, HPV testing in primary screening of older women, Br. J. Cancer, 81, 554, 10.1038/sj.bjc.6690730 Cuzick, 2000, A systematic review of the role of human papillomavirus (HPV) testing within a cervical screening program: summary and conclusions, Br. J. Cancer, 83, 561, 10.1054/bjoc.2000.1375 Franco, 1999, Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer, J. Infect. Dis., 180, 1415, 10.1086/315086 Gaarenstroom, 1994, Human papillomavirus DNA génotypes: prognostic factors for progression of cervical intraepithelial neoplasia, Int. J. Gynecol. Cancer, 4, 73, 10.1046/j.1525-1438.1994.04020073.x Gustafson, 1989, Natural history of cervical neoplasia: consistent results obtained by an identification technique, Br. J. Cancer, 60, 132, 10.1038/bjc.1989.236 Herrero, 2000, Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica, J. Natl. Cancer Inst., 92, 464, 10.1093/jnci/92.6.464 Ho, 1998, Natural history of cervicovaginal papillomavirus infection in young women, N. Engl. J. Med., 338, 423, 10.1056/NEJM199802123380703 Ho, 1995, Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia, J. Natl. Cancer Inst., 187, 1365, 10.1093/jnci/87.18.1365 Kaufman, 1999, Is human papillomavirus testing of value in clinical practice?, Am. J. Obstet. Gynecol., 180, 1049, 10.1016/S0002-9378(99)70593-4 Koutsky, 1992, A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection, N. Engl. J. Med., 327, 1272, 10.1056/NEJM199210293271804 Kulasingam, 2001, Will new human Papillomavirus diagnostics improve cervical cancer control efforts?, Curr. Infect. Dis. Rep., 3, 169, 10.1007/s11908-996-0054-0 Kuhn, 2000, Human papillomavirus DNA testing for cervical cancer screening in low-resource settings, J. Natl. Cancer Inst., 92, 818, 10.1093/jnci/92.10.818 Lorincz, 1996, Hybrid capture method for detection of human papillomavirus DNA in clinical specimens, Papillomavirus Rep., 7, 1 Lorincz, 1992, Human papillomavirus infection of the cervix: relative risk association of 15 common anogenital types, Obstet. Gynecol., 79, 328, 10.1097/00006250-199203000-00002 Manos, 1999, Identifying women with cervical neoplasia using human papillomavirus testing for equivocal Papanicolaou results, JAMA, 281, 1605, 10.1001/jama.281.17.1605 Meijer, 1998, HPV typing and testing in gynaecological pathology; has the time come?, Histopathology, 33, 83, 10.1046/j.1365-2559.1998.00436.x Meijer, 2000, Screening for cervical cancer: should we test for infection with high-risk HPV?, CMAJ, 163, 535 Monsonego, 2001, Liquid-based cytology for primary cervical cancer screening: a multi-centre study, Br. J. Cancer, 84, 360, 10.1054/bjoc.2000.1588 Nanda, 2000, Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review, Ann. Int. Med., 132, 810, 10.7326/0003-4819-132-10-200005160-00009 Nobbenhuis, 2001, Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear, Lancet, 358, 1782, 10.1016/S0140-6736(01)06809-X Nobbenhuis, 2001, Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia, Br. J. Cancer, 84, 796, 10.1054/bjoc.2000.1689 Paraskevaidis, 2001, Human Papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia, Obstet. Gynecol., 98, 833, 10.1016/S0029-7844(01)01535-6 Papillo, 1998, Evaluation of the ThinPrep Pap® test in clinical practice, Acta Cytologica, 42, 203, 10.1159/000331547 Peyton, 1998, Comparison of PCR and Hybrid Capture®-based human papillomavirus detection systems using multiple cervical specimen collection strategies, J. Clin. Microbiol., 36, 3248, 10.1128/JCM.36.11.3248-3254.1998 Ratnam, 2000, Human papillomavirus testing for primary screening of cervical cancer precursors, Cancer Epidemiol. Biomarkers Prev., 9, 945 Remmink, 1995, The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months, Int. J. Cancer, 61, 306, 10.1002/ijc.2910610305 Riethmuller, 1999, Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II® and Polymerase chain reaction, Diagn. Mol. Pathol., 8, 157, 10.1097/00019606-199909000-00009 Rozendaal, 1996, PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears, Int. J. Cancer, 68, 766, 10.1002/(SICI)1097-0215(19961211)68:6<766::AID-IJC13>3.0.CO;2-Z Schiffman, 2000, HPV DNA testing in cervical cancer screening, JAMA, 283, 87, 10.1001/jama.283.1.87 Sherman, 1998, Performance of liquid-based, thin layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing, Mod. Pathol., 11, 837 Solomon, 2001, Comparison of three management strategies for patients with atypical squamous cells of undertermined significance: baseline results from a randomized trial, J. Natl. Cancer Inst., 93, 293, 10.1093/jnci/93.4.293 Stoler, 2000, Advances in cervical screening technology, Mod. Pathol., 13, 275, 10.1038/modpathol.3880048 Stoler, 2001, Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage study, JAMA, 285, 1500, 10.1001/jama.285.11.1500 Stoler, 2001, HPV for cervical cancer screening: is the era of the molecular Pap smear upon us?, J. Histochem. Cytochem., 49, 1197, 10.1177/002215540104900918 2000, Human Papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial, J. Natl. Cancer Inst., 92, 397, 10.1093/jnci/92.5.397 Walboomers, 1999, Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide, J. Pathol., 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F Weintraub, 2000, Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with low incidence of cervical cancer, Diagn. Cytopathol., 22, 52, 10.1002/(SICI)1097-0339(200001)22:1<52::AID-DC14>3.0.CO;2-# Wright, 1998, Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears, Am. J. Obstet. Gynecol., 178, 962, 10.1016/S0002-9378(98)70531-9 Yilitalo, 2000, Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study, Lancet, 355, 2194, 10.1016/S0140-6736(00)02402-8 Zur Hausen, 1994, Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types, Curr. Top. Microbiol. Immunol., 186, 131